Elevated Phosphatidic Acid Expands ER Membrane for GPCR Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for expressing membrane proteins, particularly GPCRs, face challenges due to low abundance and difficulty in achieving sufficient quantities for structural studies, as existing expression systems result in low yields and often denatured proteins, limiting biophysical characterization and crystallization.
Innovation Solution
Eukaryotic cells with elevated phosphatidic acid levels, achieved through phosphatidic acid inhibition and diacylglycerol kinase overexpression, are used to expand the endoplasmic reticulum membrane, allowing for increased protein production and viability, enabling higher expression levels of membrane proteins like GPCRs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional expression systems are used to produce membrane proteins, then the cell structure remains normal, but the protein expression level is insufficient for structural studies
Solution Approach 1:
The patent changes the phospholipid composition parameters by increasing phosphatidic acid levels through inhibition of phosphatidic acid phosphatase and/or overexpression of diacylglycerol kinase. This parameter change leads to expanded endoplasmic reticulum membrane surface area, which directly increases the capacity for membrane protein expression and folding, thereby resolving the contradiction between protein expression level and yield.
2Quantity of substance
If membrane protein expression is increased through conventional methods, then more protein material is obtained, but the protein becomes denatured and loses functionality
Solution Approach 1:
The patent modifies the cellular phospholipid environment by increasing phosphatidic acid concentration, which changes the membrane curvature and lipid packing parameters. This creates a more favorable environment for membrane protein folding and stability, allowing high expression levels to be achieved without protein denaturation, thus resolving the contradiction between quantity and reliability.
3Productivity
If the endoplasmic reticulum membrane is expanded to increase protein production, then protein yield increases, but cell viability may be compromised
Solution Approach 1:
The patent carefully controls the phospholipid composition changes by modulating phosphatidic acid levels, which allows selective expansion of the endoplasmic reticulum membrane without excessive disruption to other cellular processes. This balanced parameter change enables increased protein production capacity while maintaining cell viability through controlled membrane remodeling.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a 10-fold or higher increase in GPCR production, ensuring sufficient quantities for biophysical characterization and maintaining protein functionality, thereby overcoming the limitations of traditional expression systems.
Implementation Method 1
derepression of phospholipid synthesis, particularly derepression of nuclear and/or endoplasmic reticulum (ER) phospholipid synthesis
Implementation Method 2
increased membrane formation from which increased levels of proteins can be recovered
Implementation Method 3
phosphatidic acid inhibition
Implementation Method 4
diacylglycerol kinase overexpression
Data Source
Figure 1A
Figure 1B~2A
Figure 2A~2B
AI summary
The present application relates to the field of protein expression technologies. More specifically, it is demonstrated that cells with increased levels of phosphatidic acid, which can be achieved through either or both of phosphatidic acid inhibition and diacylglycerol kinase overexpression, display increased membrane formation from which increased levels of proteins can be recovered.